血脂异常在糖尿病视网膜病变中的作用。
The role of dyslipidemia in diabetic retinopathy.
作者信息
Hammer Sandra S, Busik Julia V
机构信息
Department of Physiology, Michigan State University, East Lansing, MI, United States.
Department of Physiology, Michigan State University, East Lansing, MI, United States.
出版信息
Vision Res. 2017 Oct;139:228-236. doi: 10.1016/j.visres.2017.04.010. Epub 2017 May 26.
Abstract
Diabetic retinopathy (DR) affects over 93million people worldwide and is the number one cause of blindness among working age adults. These indicators coupled with the projected rise of patients diagnosed with diabetes, makes DR a serious and prevalent vision threating disease. Data from recent clinical trials demonstrate that in addition to the well accepted role of hyperglycemia, dyslipidemia is an important, but often overlooked factor in the development of DR. The central aim of this review article is to showcase the critical role of dyslipidemia in DR progression as well as highlight novel therapeutic solutions that take advantage of the vital roles lipid metabolism plays in DR progression.
摘要
糖尿病视网膜病变（DR）在全球影响着超过9300万人，是工作年龄成年人失明的首要原因。这些指标加上预计糖尿病确诊患者数量的上升，使DR成为一种严重且普遍的视力威胁性疾病。近期临床试验数据表明，除了高血糖已被广泛认可的作用外，血脂异常是DR发生发展中的一个重要但常被忽视的因素。这篇综述文章的核心目的是展示血脂异常在DR进展中的关键作用，并强调利用脂质代谢在DR进展中所起的重要作用的新型治疗方案。
相似文献
1
The role of dyslipidemia in diabetic retinopathy.血脂异常在糖尿病视网膜病变中的作用。
Vision Res. 2017 Oct;139:228-236. doi: 10.1016/j.visres.2017.04.010. Epub 2017 May 26.
2
The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.糖尿病视网膜病变发病机制的统一关键脂质调节剂、Sirtuin 1 和肝 X 受体。
EBioMedicine. 2017 Aug;22:181-190. doi: 10.1016/j.ebiom.2017.07.008. Epub 2017 Jul 11.
3
Dyslipidemia and diabetic retinopathy.血脂异常与糖尿病视网膜病变。
Rev Diabet Stud. 2013 Summer-Fall;10(2-3):121-32. doi: 10.1900/RDS.2013.10.121. Epub 2013 Aug 10.
4
Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives.血脂异常和高血糖在糖尿病视网膜病变中的新作用：分子机制和临床观点。
Front Endocrinol (Lausanne). 2021 Mar 22;12:620045. doi: 10.3389/fendo.2021.620045. eCollection 2021.
5
Diabetic retinopathy--biomolecules and multiple pathophysiology.糖尿病视网膜病变——生物分子与多种病理生理学
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):51-4. doi: 10.1016/j.dsx.2014.09.011. Epub 2014 Oct 24.
6
Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy.miR-15a在糖尿病视网膜病变中的双重抗炎和抗血管生成作用
EBioMedicine. 2016 Sep;11:138-150. doi: 10.1016/j.ebiom.2016.08.013. Epub 2016 Aug 8.
7
Preventing diabetic retinopathy through control of systemic factors.通过控制全身因素预防糖尿病性视网膜病变。
Curr Opin Ophthalmol. 2003 Dec;14(6):389-94. doi: 10.1097/00055735-200312000-00012.
8
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.糖尿病性视网膜病变的生化和分子机制的研究进展。
Biomed Pharmacother. 2015 Aug;74:145-7. doi: 10.1016/j.biopha.2015.08.002. Epub 2015 Aug 13.
9
[Modern understanding of the pathogenesis of pre-proliferative diabetic retinopathy].
Vestn Ross Akad Med Nauk. 2003(5):44-7.
10
Role of microRNAs in the modulation of diabetic retinopathy.miRNAs 在糖尿病视网膜病变调节中的作用。
Prog Retin Eye Res. 2014 Nov;43:92-107. doi: 10.1016/j.preteyeres.2014.07.003. Epub 2014 Aug 14.
引用本文的文献
1
Vitamin D deficiency and diabetic retinopathy risk in patients with newly diagnosed type 2 diabetes mellitus: a retrospective analysis.新诊断2型糖尿病患者维生素D缺乏与糖尿病视网膜病变风险：一项回顾性分析
Front Nutr. 2025 May 30;12:1614287. doi: 10.3389/fnut.2025.1614287. eCollection 2025.
2
Apolipoprotein and menopausal status are significant influencing factors for diabetic retinopathy in type II diabetes mellitus women.载脂蛋白和绝经状态是II型糖尿病女性糖尿病视网膜病变的重要影响因素。
Sci Rep. 2025 Mar 14;15(1):8868. doi: 10.1038/s41598-025-93161-8.
3
The Role of Diet and Oral Supplementation for the Management of Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review.饮食与口服补充剂在糖尿病视网膜病变和糖尿病黄斑水肿管理中的作用：一项叙述性综述
Biomed Res Int. 2025 Feb 24;2025:6654976. doi: 10.1155/bmri/6654976. eCollection 2025.
4
Modelling neurodegeneration and inflammation in early diabetic retinopathy using 3D human retinal organoids.使用3D人视网膜类器官模拟早期糖尿病视网膜病变中的神经退行性变和炎症。
In Vitro Model. 2024 Mar 25;3(1):33-48. doi: 10.1007/s44164-024-00068-1. eCollection 2024 Feb.
5
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病中的视网膜病变
Medicina (Kaunas). 2024 Dec 30;61(1):38. doi: 10.3390/medicina61010038.
6
Risk factors for diabetic retinopathy in young and middle-aged patients: a retrospective study.中青年糖尿病视网膜病变的危险因素：一项回顾性研究。
BMC Ophthalmol. 2024 Dec 23;24(1):544. doi: 10.1186/s12886-024-03821-y.
7
QiMing granules for diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials.芪明颗粒治疗糖尿病视网膜病变：一项随机对照试验的系统评价和Meta分析
Front Pharmacol. 2024 Aug 22;15:1429071. doi: 10.3389/fphar.2024.1429071. eCollection 2024.
8
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.糖尿病性视网膜病变是一种神经酰胺病，可通过抗神经酰胺免疫疗法逆转。
Cell Metab. 2024 Jul 2;36(7):1521-1533.e5. doi: 10.1016/j.cmet.2024.04.013. Epub 2024 May 7.
9
Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study.他汀类药物作为糖尿病视网膜病变的风险因素：一项孟德尔随机化和横断面观察性研究。
J Transl Med. 2024 Mar 22;22(1):298. doi: 10.1186/s12967-024-05097-8.
10
Hyperlipidemia and lipid-lowering therapy in diabetic retinopathy (DR): A bibliometric study and visualization analysis in 1993-2023.糖尿病视网膜病变（DR）中的高脂血症与降脂治疗：1993 - 2023年文献计量学研究与可视化分析
Heliyon. 2023 Oct 17;9(10):e21109. doi: 10.1016/j.heliyon.2023.e21109. eCollection 2023 Oct.
本文引用的文献
1
Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation.环氧化脂肪酸抑制视网膜血管炎症。
Sci Rep. 2016 Dec 14;6:39211. doi: 10.1038/srep39211.
2
Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial.饮食中的海洋ω-3脂肪酸与2型糖尿病中老年患者发生威胁视力的视网膜病变的关系：PREDIMED试验的前瞻性研究
JAMA Ophthalmol. 2016 Oct 1;134(10):1142-1149. doi: 10.1001/jamaophthalmol.2016.2906.
3
Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy.miR-15a在糖尿病视网膜病变中的双重抗炎和抗血管生成作用
EBioMedicine. 2016 Sep;11:138-150. doi: 10.1016/j.ebiom.2016.08.013. Epub 2016 Aug 8.
4
Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.糖尿病控制心血管风险行动（ACCORD）后续研究中强化血糖控制对2型糖尿病视网膜病变的持续影响。
Diabetes Care. 2016 Jul;39(7):1089-100. doi: 10.2337/dc16-0024. Epub 2016 Jun 11.
5
Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.糖尿病视网膜病变中促炎和血管修复性骨髓来源细胞动员与激活的失衡
PLoS One. 2016 Jan 13;11(1):e0146829. doi: 10.1371/journal.pone.0146829. eCollection 2016.
6
Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.酸性鞘磷脂酶在糖尿病视网膜病变中促炎与修复性骨髓细胞平衡转变中的作用
Stem Cells. 2016 Apr;34(4):972-83. doi: 10.1002/stem.2259. Epub 2016 Jan 4.
7
Subfraction analysis of circulating lipoproteins in a patient with Tangier disease due to a novel ABCA1 mutation.一名因新型ABCA1突变导致患有丹吉尔病患者的循环脂蛋白亚组分分析。
Clin Chim Acta. 2016 Jan 15;452:167-72. doi: 10.1016/j.cca.2015.11.021. Epub 2015 Nov 23.
8
Lipoxins: nature's way to resolve inflammation.脂氧素：机体消除炎症的天然方式。
J Inflamm Res. 2015 Sep 30;8:181-92. doi: 10.2147/JIR.S90380. eCollection 2015.
9
Diabetic Retinopathy: Vascular and Inflammatory Disease.糖尿病视网膜病变：血管性和炎症性疾病
J Diabetes Res. 2015;2015:582060. doi: 10.1155/2015/582060. Epub 2015 Jun 7.
10
Acid sphingomyelinase (aSMase) deficiency leads to abnormal microglia behavior and disturbed retinal function.酸性鞘磷脂酶（aSMase）缺乏会导致小胶质细胞行为异常和视网膜功能紊乱。
Biochem Biophys Res Commun. 2015 Aug 21;464(2):434-40. doi: 10.1016/j.bbrc.2015.06.133. Epub 2015 Jun 27.
Zotero 插件